Introduction: Heart disease in children associated with COVID-19 is described during acute infection or in the context of the Multisystem inflammatory syndrome in children (MIS-C), and in patients with and without previous heart disease. It has different manifestations: asymptomatic, with alterations in complementary tests (elevated troponins, arrhythmias, imaging changes), up to severe forms: myocardial infarction, heart failure, cardiogenic shock, sudden death. We report a schoolgirl who had severe COVID-19, with cardiac, digestive, and respiratory manifestations. Clinical case: 10-year-old girl, carrier of disabling chronic disease. In the course of severe COVID-19, she added shock and respiratory failure, elevated inflammatory markers, increased troponins, and dilated cardiac cavities, with functional compromise of the left ventricle. She received non-invasive ventilatory assistance, antibiotics, and systemic corticosteroids. Cardiac manifestations reversed, with a decrease in inflammatory parameters. Discussion: The heart is frequently affected in COVID-19. Cardiac injury may be due to: viral replication, systemic inflammatory response, respiratory failure, or myocardial stress. The severity will depend on the extent of the damage and the inflammatory response. Cardiac involvement is more common in those who meet MIS-C criteria. Most recover cardiac function. The case report contributes to the knowledge of SARS-CoV-2 infection, and the severe forms of presentation with cardiac involvement in children highlight the need to advance in primary prevention by vaccines in the pediatric population.
| Published in | Central African Journal of Public Health (Volume 7, Issue 5) |
| DOI | 10.11648/j.cajph.20210705.12 |
| Page(s) | 245-249 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Cardiac Disease, Children, COVID-19, SARS-CoV-2
| [1] | COVID-19 epidemiological report. Update to June 15, 2021. General Directorate of Health. Epidemiological division. Health Surveillance Department. Ministry of Public Health. Available in: https://www.gub.uy/ministerio-salud-publica/comunicacion/noticias/informe-epidemiologico-COVID-19-actualizado-3-junio-2021#. |
| [2] | Guo CX, He L, Yin J-Y, Meng X-G, Tan W, Yang GP, et al. Epidemiological and clinical features of pediatric COVID-19. BMC Medicine. 2020; 18: 250. |
| [3] | Hoanga A, Choratha K, Moreirab A, Evansa M, Burmeister-Mortona F, Burmeistera F, et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020; 24: 100433. |
| [4] | Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA. Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr. 2020; 179: 1079–1087. https://doi.org/10.1007/s00431-020-03699-0. |
| [5] | Valverde et al. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe. Circulation. 2021; 143: 21–32. DOI: 10.1161/CIRCULATIONAHA.120.050065. |
| [6] | Rodriguez-Gonzalez M, Castellano-Martinez A, Cascales-Poyatos HM, Perez Reviriego AA. Cardiovascular impact of COVID-19 with a focus on children: A systematic review. World J Clin Cases 2020; 8 (21): 5250-5283. |
| [7] | Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. Int J Infect Dis. 2021 Feb; 103: 246-256. doi: 10.1016/j.ijid.2020.11.163. Epub 2020 Nov 20. PMID: 33227520; PMCID: PMC7679116. |
| [8] | Caforio ALP. Coronavirus disease 2019 (COVID-19): Cardiac manifestations in adults. En: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. (Consultado el 22 de febrero de 2021). |
| [9] | ACC Clinical Bulletin. COVID-19 Clinical Guidance For the Cardiovascular Care Team. Expert advisors: Mohammad Madjid, Scott D Solomon, Orly Vardeny. March 6, 2020. |
| [10] | Centers for Disease Control and Prevention, COVID-19 Response. Access to public surveillance data for COVID-19 cases, summary and limitations (version date: January 31, 2021). |
| [11] | Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020; 48 (5): 773-777. doi: 10.1007/s15010-020-01424-5. |
| [12] | Wang D, Li S, Jiang J, Yan J, Zhao C, Wang Y, et al. Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis. Sci China Life Sci. 2019; 62 (2): 187–202. https://doi.org/10.1007/s11427-018-9385-3. |
| [13] | Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, et al. Immunology of COVID-19: current state of the science. Immunity 2020; 52: 910-41. doi: 10.1016/j.immuni.2020.05.002. |
| [14] | Nguyen Q, Lim KRQ, Yokota T. Comprensión actual y tratamiento de la patología del músculo cardíaco y esquelético en la distrofia muscular congénita con deficiencia de cadena de laminina-α2. Appl Clin Genet. 2019; 12: 113-130. https://doi.org/10.2147/TACG.S187481. |
| [15] | Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Billig Rose E, Dapul H, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021 Feb 24. doi: 10.1001/jama.2021.2091. |
APA Style
Emilia Alonso Zurmendi, Federica Badía De Ferrari, Maren Karina Machado Echeverría, Mariangel Ospitaleche, María Catalina Pirez García. (2021). Heart Disease Associated with COVID-19 in Children. Central African Journal of Public Health, 7(5), 245-249. https://doi.org/10.11648/j.cajph.20210705.12
ACS Style
Emilia Alonso Zurmendi; Federica Badía De Ferrari; Maren Karina Machado Echeverría; Mariangel Ospitaleche; María Catalina Pirez García. Heart Disease Associated with COVID-19 in Children. Cent. Afr. J. Public Health 2021, 7(5), 245-249. doi: 10.11648/j.cajph.20210705.12
AMA Style
Emilia Alonso Zurmendi, Federica Badía De Ferrari, Maren Karina Machado Echeverría, Mariangel Ospitaleche, María Catalina Pirez García. Heart Disease Associated with COVID-19 in Children. Cent Afr J Public Health. 2021;7(5):245-249. doi: 10.11648/j.cajph.20210705.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.cajph.20210705.12,
author = {Emilia Alonso Zurmendi and Federica Badía De Ferrari and Maren Karina Machado Echeverría and Mariangel Ospitaleche and María Catalina Pirez García},
title = {Heart Disease Associated with COVID-19 in Children},
journal = {Central African Journal of Public Health},
volume = {7},
number = {5},
pages = {245-249},
doi = {10.11648/j.cajph.20210705.12},
url = {https://doi.org/10.11648/j.cajph.20210705.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20210705.12},
abstract = {Introduction: Heart disease in children associated with COVID-19 is described during acute infection or in the context of the Multisystem inflammatory syndrome in children (MIS-C), and in patients with and without previous heart disease. It has different manifestations: asymptomatic, with alterations in complementary tests (elevated troponins, arrhythmias, imaging changes), up to severe forms: myocardial infarction, heart failure, cardiogenic shock, sudden death. We report a schoolgirl who had severe COVID-19, with cardiac, digestive, and respiratory manifestations. Clinical case: 10-year-old girl, carrier of disabling chronic disease. In the course of severe COVID-19, she added shock and respiratory failure, elevated inflammatory markers, increased troponins, and dilated cardiac cavities, with functional compromise of the left ventricle. She received non-invasive ventilatory assistance, antibiotics, and systemic corticosteroids. Cardiac manifestations reversed, with a decrease in inflammatory parameters. Discussion: The heart is frequently affected in COVID-19. Cardiac injury may be due to: viral replication, systemic inflammatory response, respiratory failure, or myocardial stress. The severity will depend on the extent of the damage and the inflammatory response. Cardiac involvement is more common in those who meet MIS-C criteria. Most recover cardiac function. The case report contributes to the knowledge of SARS-CoV-2 infection, and the severe forms of presentation with cardiac involvement in children highlight the need to advance in primary prevention by vaccines in the pediatric population.},
year = {2021}
}
TY - JOUR T1 - Heart Disease Associated with COVID-19 in Children AU - Emilia Alonso Zurmendi AU - Federica Badía De Ferrari AU - Maren Karina Machado Echeverría AU - Mariangel Ospitaleche AU - María Catalina Pirez García Y1 - 2021/10/30 PY - 2021 N1 - https://doi.org/10.11648/j.cajph.20210705.12 DO - 10.11648/j.cajph.20210705.12 T2 - Central African Journal of Public Health JF - Central African Journal of Public Health JO - Central African Journal of Public Health SP - 245 EP - 249 PB - Science Publishing Group SN - 2575-5781 UR - https://doi.org/10.11648/j.cajph.20210705.12 AB - Introduction: Heart disease in children associated with COVID-19 is described during acute infection or in the context of the Multisystem inflammatory syndrome in children (MIS-C), and in patients with and without previous heart disease. It has different manifestations: asymptomatic, with alterations in complementary tests (elevated troponins, arrhythmias, imaging changes), up to severe forms: myocardial infarction, heart failure, cardiogenic shock, sudden death. We report a schoolgirl who had severe COVID-19, with cardiac, digestive, and respiratory manifestations. Clinical case: 10-year-old girl, carrier of disabling chronic disease. In the course of severe COVID-19, she added shock and respiratory failure, elevated inflammatory markers, increased troponins, and dilated cardiac cavities, with functional compromise of the left ventricle. She received non-invasive ventilatory assistance, antibiotics, and systemic corticosteroids. Cardiac manifestations reversed, with a decrease in inflammatory parameters. Discussion: The heart is frequently affected in COVID-19. Cardiac injury may be due to: viral replication, systemic inflammatory response, respiratory failure, or myocardial stress. The severity will depend on the extent of the damage and the inflammatory response. Cardiac involvement is more common in those who meet MIS-C criteria. Most recover cardiac function. The case report contributes to the knowledge of SARS-CoV-2 infection, and the severe forms of presentation with cardiac involvement in children highlight the need to advance in primary prevention by vaccines in the pediatric population. VL - 7 IS - 5 ER -
Information
Email: